TNF receptor 1, IL-1 receptor, and iNOS genetic knockout mice are not protected from anthrax infection

John Kalns1, Julie Scruggs, Nancy Millenbaugh

  • 1Davis Hyperbaric Laboratory, 2602 West Gate Road, Brooks Air Force Base, TX 78235-5252, USA. john.kalns@brooks.af.mil

Insights

Investigating the immune response to anthrax, this study found that while most immune system knockouts had similar survival rates, some, like IL-1 receptor and iNOS knockouts, died sooner, indicating a complex role in disease progression.

Area of Science:

  • Immunology
  • Microbiology
  • Pathology

Background:

  • Bacillus anthracis toxins induce severe systemic inflammation, shock, and death.
  • The specific roles of immune system components in anthrax mortality and disease progression remain unclear.

Purpose of the Study:

  • To investigate the impact of specific immune system components on the host response to anthrax infection.
  • To determine if genetic deficiencies in the immune system alter susceptibility or disease course in a murine model.

Main Methods:

  • Parent strain mice and knockout mice lacking specific immune factors were subcutaneously challenged with a lethal dose (LD95) of anthrax spores.
  • Survival rates, bacterial burden at the injection site, and pathological changes were assessed.

Main Results:

  • All genetic knockouts exhibited similar mortality frequencies compared to parent strain mice.
  • Tumor necrosis factor (TNF) antibody administration delayed death, but TNF receptor 1 knockout mice showed no difference in survival.
  • Interleukin-1 receptor (IL-1R) and inducible nitric oxide synthase (iNOS) knockout mice succumbed to infection more rapidly.
  • Increased anthrax burden at the injection site was observed in TNF-alpha and iNOS knockouts, suggesting impaired cellular response.

Conclusions:

  • While overall mortality was not significantly altered by most immune gene knockouts, specific pathways like IL-1R and iNOS play a critical role in controlling early infection.
  • An attenuated cellular immune response, as seen in iNOS knockouts, may accelerate anthrax disease progression.
  • Pathological changes were primarily localized to the injection site, with minimal systemic organ damage observed.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inhalation Anthrax01:25

Inhalation Anthrax

Anthrax is a zoonotic disease caused by Bacillus anthracis, a Gram-positive, spore-forming bacterium. It primarily affects herbivorous animals but can be transmitted to humans through skin contact, ingestion, or inhalation of spores.Cutaneous anthrax, the most common form, typically results from direct contact with bacterial spores through skin abrasions and is generally less severe. Gastrointestinal anthrax results from eating undercooked or contaminated meat. It affects the mouth, throat, or...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...